BREAKING
Cisco (CSCO) Q2 FY26 earnings beat estimates; revenue up 10% 3 hours ago Earnings Summary: Martin Marietta Materials reports Q4 2025 financial results 4 hours ago Earnings Summary: Kraft Heinz’s Q4 2025 earnings decline on lower sales 11 hours ago Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues 12 hours ago Mattel Q4 2025 Earnings Show Mixed Performance in Q4 Report 12 hours ago Key highlights from Humana’s (HUM) Q4 2025 earnings results 13 hours ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 1 day ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 days ago Cisco (CSCO) Q2 FY26 earnings beat estimates; revenue up 10% 3 hours ago Earnings Summary: Martin Marietta Materials reports Q4 2025 financial results 4 hours ago Earnings Summary: Kraft Heinz’s Q4 2025 earnings decline on lower sales 11 hours ago Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues 12 hours ago Mattel Q4 2025 Earnings Show Mixed Performance in Q4 Report 12 hours ago Key highlights from Humana’s (HUM) Q4 2025 earnings results 13 hours ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 1 day ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 days ago
ADVERTISEMENT
Analysis

Solstice shares jump after fourth-quarter sales rise and guidance provided

$SOLS February 11, 2026 3 min read

Solstice Advanced Materials Inc. (Nasdaq: SOLS) closed at $72.44, up 13.6% on the day after the company released fourth-quarter and full-year 2025 results and provided 2026 guidance. Solstice’s market capitalization at the latest close was approximately $11.50 billion based on the reported float and the intraday price.

 

Latest Quarterly Results (Q4 2025)

Consolidated net sales for the quarter ended Dec. 31, 2025, were $987 million, an increase of 8% year over year. Net income attributable to Solstice for the quarter was $41 million. Adjusted standalone EBITDA for the quarter was $189 million, with an adjusted standalone EBITDA margin of 19.1%. The quarter’s top-line growth was driven by double-digit increases in Nuclear (Alternative Energy Services), Electronic Materials, and Refrigerants, partially offset by lower volumes in Healthcare Packaging.

 

Full‑Year Results Context

For the full year 2025, consolidated net sales were $3,886 million, up 3% from the prior year. Net income attributable to Solstice for the year was $237 million. Adjusted standalone EBITDA for the year totaled $957 million, with an adjusted standalone EBITDA margin of 24.6%. Full‑year results reflected higher revenue in Refrigerants and Electronic Materials, alongside higher costs and separation-related items that weighed on margin and net income comparisons to the prior year.

ADVERTISEMENT

 

Business & Operations Update

Management highlighted ongoing momentum in Refrigerants, Nuclear (AES), and Electronic Materials. The company plans capacity expansion at its Metropolis conversion facility and expects production increases supported in part by Department of Energy initiatives. The firm reported a robust backlog and said current contracted capacity extends into 2030 for key customers. Capital spending for the year was elevated to support growth initiatives and capacity investments.

 

M&A or Strategic Moves

No material acquisitions or divestitures were announced with the results. The company said it remains open to selective M&A to accelerate capability expansion while prioritizing disciplined capital allocation and high returns on invested capital.

 

ADVERTISEMENT

Equity Analyst Commentary

Post‑release discussions focused on margin headwinds from transitory costs and plant downtime, the impact of refrigerant product mix, and the trajectory of nuclear-related revenue contributions. Analysts also noted the company’s dividend initiation and capital allocation stance.

 

Guidance & Outlook — what to watch for

Solstice provided full‑year 2026 guidance of net sales in a range of $3,900 million to $4,100 million and adjusted EBITDA of $975 million to $1,025 million. Adjusted diluted EPS guidance was given as $2.45 to $2.75. Items to watch include execution of capacity expansions, removal of transitory cost items, inventory and mix dynamics, and the company’s progress on nuclear conversion output.

 

Performance Summary

Shares rose after the quarterly release. Q4 net sales were $987 million, and adjusted standalone EBITDA was $189 million. Full-year net sales were $3,886 million. Management authorized a quarterly dividend of $0.075 per share and signaled continued investment in capacity and technology.

ADVERTISEMENT
ADVERTISEMENT